Perbedaan Indofarma Tbk. dan Sinarmas Multiartha Tbk.: Indofarma Tbk. diperdagangkan di Rp126 (kapitalisasi pasar 390,51 M), sedangkan Sinarmas Multiartha Tbk. diperdagangkan di Rp20.025 (kapitalisasi pasar 127,51 T, volume 24 jam 300). Perbedaan utamanya: Sinarmas Multiartha Tbk. jauh lebih besar — sekitar 326,5× kapitalisasi pasar Indofarma Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| INAF | SMMA | |
|---|---|---|
Kapitalisasi Pasar | 390,51 M | 127,51 T |
Volume | — | 300 |
Lot | — | 3 |
Perputaran | — | 6 jt |
Harga Rata-rata | — | 20.008,33 |
Nilai Transaksi | — | 6 jt |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.
Selengkapnya di halaman INAF →PT Sinar Mas Multiartha Tbk was established by Deed No. 60 dated October 21, 1982 from Benny Kristianto, S.H., notary in Jakarta. PT Sinar Mas Multiartha was initially active in commercial leasing, consumer financing and venture capital, and purely became a holding company in the Sinar Mas Group.
Selengkapnya di halaman SMMA →